As of 2025-05-16, the Intrinsic Value of Biohit Oyj (BIOBV.HE) is 3.95 EUR. This BIOBV.HE valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 2.70 EUR, the upside of Biohit Oyj is 46.40%.
The range of the Intrinsic Value is 2.69 - 8.32 EUR
Based on its market price of 2.70 EUR and our intrinsic valuation, Biohit Oyj (BIOBV.HE) is undervalued by 46.40%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 2.69 - 8.32 | 3.95 | 46.4% |
| DCF (Growth 10y) | 3.52 - 10.87 | 5.18 | 91.9% |
| DCF (EBITDA 5y) | 3.89 - 6.02 | 4.96 | 83.8% |
| DCF (EBITDA 10y) | 4.73 - 8.03 | 6.26 | 132.0% |
| Fair Value | 4.44 - 4.44 | 4.44 | 64.54% |
| P/E | 1.58 - 6.78 | 3.47 | 28.4% |
| EV/EBITDA | 2.62 - 4.75 | 3.86 | 42.9% |
| EPV | 3.71 - 6.09 | 4.90 | 81.6% |
| DDM - Stable | 1.63 - 7.02 | 4.33 | 60.3% |
| DDM - Multi | 2.60 - 9.13 | 4.10 | 51.8% |
| Market Cap (mil) | 40.54 |
| Beta | 0.18 |
| Outstanding shares (mil) | 15.01 |
| Enterprise Value (mil) | 37.42 |
| Market risk premium | 5.68% |
| Cost of Equity | 6.95% |
| Cost of Debt | 14.22% |
| WACC | 7.03% |